Abstract
REGN5458, a BCMA x CD3 Bispecific Monoclonal Antibody, Induces Deep and Durable Responses in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have